Medicine
Cnj-016 1 IU/mL injection
Cnj-016 1 IU/mL injection is a prescription medicine containing Human vaccinia virus immune globulin for intravenous use, marketed by Emergent BioSolutions Canada, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Use within 60 days of thawing at 2°C to 8°C (36°F to 46°F). Product is stored…
Key facts
- Active ingredient (INN)
- Human vaccinia virus immune globulin
- Brand
- Cnj-016
- Strength
- 1 IU/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 24 vials
- Marketing authorisation holder
- Emergent BioSolutions Canada
- Manufacturer
- Emergent BioSolutions Canada
- Origin register
- US FDA, United States
- Storage
- Use within 60 days of thawing at 2°C to 8°C (36°F to 46°F). Product is stored frozen at or below -15°C (≤5°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 May 2005
- Identifiers
- RxCUI 1922329, 1922334DailyMed set ID a4f9f620-e6e4-4a03-a9a7-79007c8c2cfeNDC 60492-0173Application BLA125109
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 24 vial, single-use in 1 carton / 12 mL in 1 vial, single-use | 60492-0173-2 | Emergent BioSolutions Canada | 12 January 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Human vaccinia virus immune globulin is a human immunoglobulin G indicated for the treatment and/or modification of conditions, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Human vaccinia virus immune globulin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Human vaccinia virus immune globulinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- CNJ-016 prescribing information (Emergent BioSolutions Canada) · U.S. National Library of Medicine, DailyMed
Need Cnj-016 1 IU/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.